Key Factors Anticipated To Propel Market Revenue Growth over the Projected Period Include Rising Rates of Adult and Adolescent Scoliosis, Growing Biomaterial Usage in Spinal Implants, And Increased Accessibility to Spinal Fusion Procedures
Seoul, South Korea, July 29, 2022 (GLOBE NEWSWIRE) -- As per industry analysis by Fact.MR, a market research and competitive intelligence provider, the global spinal surgery products market is projected to expand at a CAGR of 4.3% and reach a market value of US$ 15.5 billion by the end of 2030.
The market is divided into degenerative disc disease, traumas & fractures, complicated deformities, and others based on disease indication. Due to the rising number of disc replacement procedures and the increased demand for artificial discs, degenerative disc disease is predicted to hold the largest share of the market in 2022. One of the most common problems in the world today is lower back pain, which is predicted to favour the growth of the degenerative disc disease market.
For Critical Insights on Spinal Surgery Products Market, Request a Sample Report https://www.factmr.com/connectus/sample?flag=S&rep_id=7559
Increase in the number of births with abnormalities causing modification or misalignment in the spinal column and rising elderly population are predicted to drive the complicated deformity sector. The traumas & fractures market is expected to grow significantly between 2022 and 2030 due to the rise in spinal injuries and fractures, attractive reimbursement scenario, and the need for less invasive procedures.
Which Regions Should Spinal Surgery Product Manufacturers Focus On?
“Presence of Key Market Players & High Prevalence of Chronic Illnesses Driving Sales of Spinal Surgery Equipment in North America & Europe”
The market is anticipated to be dominated by North America throughout the forecast period. The reasons for North America's dominance in the global market are new product releases, strategic alliances, increasing biologics research, and an increase in the prevalence of spinal illnesses.
The main factors driving market expansion in Europe include favourable health reimbursement, strong demand for medical equipment in Germany and the U.K., and rising rates of spine surgery. It is anticipated that government funding and active investment will dominate the Europe market.
Due to the rising geriatric population, increasing prevalence of degenerative illnesses, and lower back discomfort, the demand for orthopedic spine devices in the Asia Pacific region is anticipated to soar during the projected period.
One of the main factors boosting the spine surgery products market in Latin America, the Middle East, and Africa is the expansion of prominent manufacturers' distribution networks in emerging countries and rising healthcare spending.
To learn more about Spinal Surgery Products Market, you can get in touch with our Analyst at https://www.factmr.com/connectus/sample?flag=AE&rep_id=7559
Key Segments Covered in the Spinal Surgery Products Industry Survey
Key players are engaging in a variety of strategic measures to increase their market shares, including mergers and acquisitions, technology partnerships, collaborations, and the creation and introduction of cutting-edge products.
Cohere TLIF-O implant and Cohere TLIF-A implant for posterior spine surgery were both introduced by NuVasive in October 2021.
Stryker declared a definitive merger agreement in January 2022, under which, it would pay US$ 79.25 per share, or a total equity value of roughly US$ 2.97 billion, and a total estimated value of roughly US$ 3.09 billion, to procure all the issued and outstanding shares of common stock of Vocera Communications, Inc.
Get Customization on Spinal Surgery Products Market Report for Specific Research Solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=7559
Key players in the Spinal Surgery Products Market
Ulrich GmbH & Co. KG
Key Takeaways from Spinal Surgery Products Market Study
The global spinal surgery products market is set to reach a valuation of US$ 15.5 billion by 2030.
Demand for spinal surgery products is expected to rise at a CAGR of 4.3% from 2022 to 2030.
Due to the rising number of Americans experiencing lower back pain and other ailments related to the spine each year, the United States currently holds a dominant position in the North America market for spinal surgery devices.
As more spinal fusion procedures are performed, spinal fusion equipment is expected to hold the highest market share in 2022. High growth has been brought on by technological advancements in spine fusion surgeries, whether internal fixation is used or not.
Fact.MR’s Domain Expertise in Healthcare Sector
Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.
Explore Fact.MR's Coverage on the Healthcare Domain-
Gene Therapy Market- The global gene therapy market is slated to acquire a valuation of US$ 1.85 Billion in 2022, up from US$ 1.55 Billion in 2021, representing a Y-o-Y increase of 19.3%. From 2022-2032, the market is poised to register a CAGR of 18.5%, reaching a valuation of US$ 10.1 Billion.
Diagnostic Imaging Services Market- Demand for diagnostic imaging services reached a valuation of US$ 555 Million in 2021, and is projected to reach US$ 585 Million in 2022, exhibiting a Y-o-Y growth rate of 5.4%. From 2022 to 2032, the industry is poised to grow at a CAGR of 5.51% to reach a valuation of US$ 1 Billion.
Drug Delivery Systems Market- The worldwide drug delivery systems market was worth around US$ 40 Billion in 2022 and is expected to grow at a CAGR of more than 7.8% from 2022 to 2032, reaching roughly US$ 80 Billion by 2032.
Medical Waste Management Market- The global medical waste management market, which projects market growth at a CAGR of 6.2% from 2021 to 2028. Revenue from medical waste management services accounted for US$ 15.3 Bn in 2020, and is estimated to surge to US$ 25.2 Bn by the end of 2028.
Heart Attack Diagnostics Market- The heart attack diagnostics market is predicted to grow at a moderate CAGR of 7.1% during the forecast period of 2022 to 2032. The global heart attack diagnostics market is estimated to reach a value of nearly US$ 22.2 Billion by 2032 by growing from US$ 10.4 Billion in 2021.
Drug Discovery Services Market- The drug discovery services market is forecasted to reach US$ 50 Billion by 2032, up from US$ 19 Billion in 2022, at a CAGR of 10.1%. A Y-o-Y growth rate of nearly 12% is expected for the market in 2022. As of 2021, the market was valued at US$ 17 Billion.
Lab Automation Market- Demand for lab automation services experienced a Y-o-Y expansion rate of over 11% in 2022 compared to 2021, rising from US$ 1.8 Billion to US$ 2 Billion. Going forward, the market is poised to flourish at a 7% value CAGR from 2022-2032, reaching a valuation of nearly US$ 4 Billion.
Patient Engagement Solutions Market- The global patient engagement solutions market, the market is gaining traction steadily, rising at an 8.6% CAGR through 2032, exceeding a valuation of around US$ 29 Billion by 2022. As of the end of 2032, the market is expected to reach US$ 66.4 Billion.
Smart Implants Market- The global smart implants market is estimated at US$ 3.9 billion in 2022, and is forecast to surpass a market value of US$ 22.2 billion by 2032. Smart implants are expected to contribute significantly to the global implants market, with demand surging at a CAGR of 19% from 2022 to 2032.
Facial Implants Market- The global facial implant market was valued at US$ 2.7 Billion in 2022, and is expected to rise at a 7.7% value CAGR, likely to reach US$ 5.6 Billion by the end of the 2022-2032 forecast period.
About Us: Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact: Mahendra Singh US Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 Email: sales@factmr.com Tel: +1 (628) 251-1583 Follow Us: LinkedIn | Twitter
Yahoo Finance Live anchors discuss Nvidia releasing preliminary revenue numbers.
It seems that most of the bad performance of Bed Bath & Beyond ( NASDAQ:BBBY ) is attributable to the negative performance history after 2019. The stock is beaten down by short-selling, with some 35% of shares being shorted by July 14th, 2022, and analysts are also posting low price targets for the stock which has driven it to a multi-year low valuation.
Alibaba Group Holding Limited ( NYSE:BABA ) just released the latest earnings report for the quarter ending on June 30th, showing a noticeable business slowdown based on decreased commerce activity in China. In this analysis, we will pair the risk factors for Alibaba with the fundamentals in order to see if the market is skewed in any direction.
Upstart Holdings (NASDAQ: UPST) and Affirm Holdings (NASDAQ: AFRM) were two of the market's hottest fintech stocks last year. Upstart went public at $20 per share in December 2020, started trading at $26, and soared to an all-time high of $390 last October.
Alphabet, Amazon, DexCom, Shopify, and Tesla have all announced stock splits this year -- but only one of these giants is a screaming buy.
Galaxy Digital Holdings Ltd. (TSX: GLXY) ("Galaxy Digital", "Galaxy", the "Company" or "GDH Ltd.") today released financial results for the three and six months ended June 30, 2022 for both itself and Galaxy Digital Holdings LP (the "Partnership" or "GDH LP").
Palantir tumbled as earnings missed analyst estimates while revenue edged by Wall Street targets and guidance came in below views.
Whether the stock market is near an all-time high or in a bear market, no one wants to pay more for a share of a company than it is worth. A dirt cheap dividend stock could be a company that is being valued at less than its historical metrics indicate. Phillips 66 (NYSE: PSX), Kinder Morgan (NYSE: KMI), and United Parcel Service (NYSE: UPS) are three industry-leading businesses that are all cheap stocks based on historical valuations.
Shares of Nvidia Corp. were tumbling 7% in premarket trading Monday after the semiconductor company disclosed that it expects to fall well short of revenue expectations for its latest quarter, largely due to gaming weakness.
Things didn't work out for my "three stocks to avoid" column last week. The three stocks I thought were going to lose to the market for the week -- Wayfair, TrueCar, and Tesla Motors -- rose 16%, climbed 2%, and fell 3%, respectively, averaging out to a 5% increase. The past month has been wild -- if not outright ridiculous -- for AMTD Digital.
Twitter founder Jack Dorsey calls for end to China’s Communist Party over zero-Covid policies Ryanair accuses Hungary of imposing ‘baseless’ fine over Viktor Orban’s ‘unjustified’ windfall tax FTSE 100 rises 0.8pc Andrew Orlowski: Wikipedia has become a tool of the Left in the battle to control the truth Sign up here for our daily business briefing newsletter
Few money managers have the investing track record that billionaire Warren Buffett brings to the table. Since taking over as CEO of conglomerate Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) in 1965, he's led his company's Class A shares (BRK.A) to an average annual return of 20.1%, through Dec. 31, 2021. In other words, when Warren Buffett buys or sells shares of a company, everyone from novice investors to professionals with decades of experience tends to pay close attention.
In this article, we discuss 10 stocks that will suffer if China invades Taiwan. If you want to see more stocks in this selection, click 5 Stocks That Will Suffer If China Invades Taiwan. The United States has said on many occasions that it will retaliate against China if it decides to invade Taiwan, whereas […]
Yahoo Finance anchors discuss second-quarter earnings for Palantir.
Berkshire Hathaway Inc said on Saturday that Vice Chairman Greg Abel, who is next in line to succeed billionaire Warren Buffett as chief executive, sold his 1% stake in the company's Berkshire Hathaway Energy unit for $870 million. In its quarterly report, Berkshire said the energy unit bought out Abel in June under an agreement among them and the family of the late billionaire philanthropist Walter Scott, which owns an 8% stake. Buffett's Omaha, Nebraska-based conglomerate took a $362 million charge to capital, reflecting the premium over how much the stake's value was reflected on its books.
The charts and indicators of the operator of a cloud-based artificial intelligence lending platform are largely bearish.
Advanced Micro Devices continues to deliver strong financial results, which could lead to blockbuster gains in its stock price.
The board of Walgreens Boots Alliance, Inc. ( NASDAQ:WBA ) has announced that the dividend on 9th of September will be...
U.S. stocks opened higher Monday as investors approached the final stretch of earnings season and braced for a busy week of inflation data.
Exxon Mobil Corporation ( NYSE:XOM ) posted record Q2 earnings of $17.9b, amounting to $38.95 billion in the last 12 months. This marks a 227% YoY quarterly earnings growth. Investors that were bullish on XOM a year ago are getting a solid 60% return, however we need to analyze if the abnormal market conditions will persist - or if price tailwinds have reached their peak for this cycle.